Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE S2 ( October, 2022 ) > List of Articles


Recommendations for Evaluation and Selection of Deceased Organ Donor: Position Statement of ISCCM

Kapil G Zirpe, Rahul A Pandit, Deepak Govil, Palepu B Gopal, Atul P Kulkarni, Subramanian Swaminathan, Subhal B Dixit, Arindam Kar, Rajesh K Pande, Dhruva Chaudhry

Keywords : Brain death, Donor age, Donor evaluation, Expanded criteria donor, Intensivist, Transplantation

Citation Information :

DOI: 10.5005/jp-journals-10071-24190

License: CC BY-NC 4.0

Published Online: 31-10-2022

Copyright Statement:  Copyright © 2022; The Author(s).


There is a wide gap between patients who need transplants and the organs that are available in India. Extending the standard donation criterion is certainly important to address the scarcity of organs for transplantation. Intensivists play a major role in the success of deceased donor organ transplants. Recommendations for deceased donor organ evaluation are not discussed in most intensive care guidelines. The purpose of this position statement is to establish current evidence-based recommendations for multiprofessional critical care staff in the evaluation, assessment, and selection of potential organ donors. These recommendations will give “real-world” criteria that are acceptable in the Indian context. The aim of this set of recommendations is to both increase the number and enhance the quality of transplantable organs.

PDF Share
  1. Kute V, Ramesh V, Shroff S, Guleria S, Prakash J. Deceased-donor organ transplantation in India: current status, challenges, and solutions. Exp Clin Transplant 2020;18(Suppl. 2):31–42. DOI: 10.6002/ect.rlgnsymp2020.L6.
  2. Reddy MS, Hakeem AR, Klair T, Marcon F, Mathur A, Samstein B, et al. Trinational study exploring the early impact of the COVID-19 pandemic on organ donation and liver transplantation at national and unit levels. Transplantation 2020;104(11):2234–2243. DOI: 10.1097/TP.0000000000003416.
  3. National Health Service Blood and Transplant; Donor Identification and Referral Strategy Group. Timely identification and referral of potential organ donors: a strategy for implementation of best practice. 2012.
  4. Martin-Loeches I, Sandiumenge A, Charpentier J, Kellum JA, Gaffney AM, Procaccio F, et al. Management of donation after brain death (DBD) in the ICU: the potential donor is identified, what's next? Intensive Care Med 2019;45(3):322–330. DOI: 10.1007/s00134-019-05574-5.
  5. Westphal GA, Slaviero TA, Montemezzo A, Lingiardi GT, de Souza FC, Carnin TC, et al. The effect of brain death protocol duration on potential donor losses due to cardiac arrest. Clin Transplant 2016;30(11):1411. DOI: 10.1111/ctr.12830.
  6. Vincent A, Logan L. Consent for organ donation. Br J Anaesth 2012;108(suppl. 1):i80–i87. DOI: 10.1093/bja/aer353.
  7. Simpkin AL, Robertson LC, Barber V, Young JD. Modifiable factors influencing relatives’ decision to offer organ donation: systematic review. British Medical Journal 2009;338:b991. DOI: 10.1136/bmj.b991.
  8. Kauffman HM, Bennett LE, McBride MA, Ellison MD. The expanded donor. Transplant Rev 1997;11(4):165–190. DOI: 10.1016/S0955-470X(97)80037-7.
  9. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant 2003;3:114–125. DOI: 10.1034/j.1600-6143.3.s4.11.x.
  10. Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, et al. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 2014;20:10–18. DOI: 10.1111/1469-0691.12557.
  11. Tullius SG, Rabb H. Improving the supply and quality of deceased-donor organs for transplantation. New Engl J Med 2018;378(20): 1920–1929. DOI: 10.1056/NEJMra1507080.
  12. Merion RM, Ashby VB, Wolfe RA, Distant DA, Hulbert-Shearon TE, Metzger RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. Journal of the American Medical Association 2005;294(21):2726–2733. DOI: 10.1001/jama.294.21.2726.
  13. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 1999;341(23):1725–1730. DOI: 10.1056/NEJM199912023412303.
  14. Lee KW, Park JB, Cha SR, Lee SH, Chung YJ, Yoo H, et al. Dual kidney transplantation offers a safe and effective way to use kidneys from deceased donors older than 70 years. BMC Nephrol 2020;21(1):1–7. DOI: 10.1186/s12882-019-1664-8.
  15. Heilman RL, Smith ML, Kurian SM, Huskey J, Batra RK, Chakkera HA, et al. Transplanting kidneys from deceased donors with severe acute kidney injury. Am J Transplant 2015;15(8):2143–2151. DOI: 10.1111/ajt.13260.
  16. Girolami I, Gambaro G, Ghimenton C, Beccari S, Caliò A, Brunelli M, et al. Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys. J Nephrol 2020;33(1):167–176. DOI: 10.1007/s40620-019-00638-7.
  17. Koval CE, Poggio ED, Lin YC, Kerr H, Eltemamy M, Wee A. Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: a report of 10 cases. Am J Transplant 2021;21(11):3743–3749. DOI: 10.1111/ajt.16765.
  18. Meshram HS, Kute VB, Patel H, Desai S, Chauhan S, Dave RB. A case report of successful kidney transplantation from a deceased donor with terminal COVID-19-related lung damage: ongoing dilemma between discarding and accepting organs in COVID-19 era! Transplant Infect Dis 2021;23(5):e13683. DOI: 10.1111/tid.13683.
  19. Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol 2019;70(4):745–758. DOI: 10.1016/j.jhep.2018.12.009.
  20. Mangus RS, Fridell JA, Vianna RM, Milgrom ML, Chestovich P, Vandenboom C, et al. Severe hypernatremia in deceased liver donors does not impact early transplant outcome. Transplantation 2010;90(4):438–443. DOI: 10.1097/TP.0b013e3181e764c0.
  21. Northup PG, Argo CK, Nguyen DT, McBride MA, Kumer SC, Schmitt TM, et al. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transplant Int 2010;23(10):1038–1044. DOI: 10.1111/j.1432-2277.2010.01092.x.
  22. Burr AT, Li Y, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA. Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg 2011;35(7):1590–1595. DOI: 10.1007/s00268-011-1019-5.
  23. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010;52(2):272–279. DOI: 10.1016/j.jhep.2009.11.009.
  24. Durand CM, Segev D, Sugarman J. Realizing HOPE: the ethics of organ transplantation from HIV-positive donors. Ann Intern Med 2016;165(2):138–142. DOI: 10.7326/M16-0560.
  25. Kitajima T, Moonka D, Yeddula S, Collins K, Rizzari M, Yoshida A, et al. Outcomes in living donor compared to deceased donor primary liver transplant in lower acuity patients with MELD score< 30. Liver Transpl 2021;27(7):971–983. DOI: 10.1002/lt.25993.
  26. Ziogas IA, Kakos CD, Esagian SM, Skarentzos K, Alexopoulos SP, Montenovo MI. Liver transplant after donation from controlled cardiac death vs brain death: a UNOS database analysis and publication bias adjusted meta-analysis. J Am Coll Surg 2021;233(5):e193–e194. DOI: 10.1016/j.jamcollsurg.2021.08.522.
  27. Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int 2020;14(4):429–431. DOI: 10.1007/s12072-020-10041-1.
  28. Tsao CI, Chen RJ, Chou NK, Ko WJ, Chi NH, Yu HY, et al. The influence of donor characteristics on survival after heart transplantation. Transplantation Proc 2008;40(8):2636–2637. DOI: 10.1016/j.transproceed.2008.08.026.
  29. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report—2012. J Heart Lung Transplant 2012;31(10):1052–1064. DOI: 10.1016/j.healun.2012.08.002.
  30. Al-Khaldi A, Oyer PE, Robbins RC. Outcome analysis of donor gender in heart transplantation. J Heart Lung Transplant 2006;25(4):461–468. DOI: 10.1016/j.healun.2005.11.456.
  31. Patel ND, Weiss ES, Nwakanma LU, Russell SD, Baumgartner WA, Shah AS, et al. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database. Circulation 2008;118(14_suppl_1):S83–S88. DOI: 10.1161/CIRCULATIONAHA.107.756866.
  32. Stehlik J, Feldman DS, Brown RN, VanBakel AB, Russel SD, Ewald GA, et al. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant 2010;29(3):291–298. DOI: 10.1016/j.healun.2009.08.007.
  33. Kuppahally SS, Valantine HA, Weisshaar D, Parekh H, Hung YY, Haddad F, et al. Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant 2007;7(10):2388–2395. DOI: 10.1111/j.1600-6143.2007.01930.x.
  34. Massad MG. Current trends in heart transplantation. Cardiology 2004;101(1–3):79–92. DOI: 10.1159/000075988.
  35. Venkateswaran RV, Townend JN, Wilson IC, Mascaro JG, Bonser RS, Steeds RP. Echocardiography in the potential heart donor. Transplantation 2010;89(7):894–901. DOI: 10.1097/TP.0b013e3181cfe8e9.
  36. Hadjizacharia P, Salim A, Brown C, Inaba K, Chan LS, Mascarenhas A, et al. Does the use of pulmonary artery catheters increase the number of organs available for transplantation? Clin Transplant 2010;24(1):62–66. DOI: 10.1111/j.1399-0012.2009.00980.x.
  37. Casartelli M, Bombardini T, Simion D, Gaspari MG, Procaccio F. Wait, treat and see: echocardiographic monitoring of brain-dead potential donors with stunned heart. Cardiovasc Ultrasound 2012;10(1):1–8. DOI: 10.1186/1476-7120-10-25.
  38. Kotecha S, Hobson J, Fuller J, Paul E, Levvey BJ, Whitford H, et al. Continued successful evolution of extended criteria donor lungs for transplantation. Ann Thorac Surg 2017;104(5):1702–1709. DOI: 10.1016/j.athoracsur.2017.05.042.
  39. Sommer W, Ius F, Salman J, Avsar M, Tudorache I, Kühn C, et al. Survival and spirometry outcomes after lung transplantation from donors aged 70 years and older. J Heart Lung Transplant 2015;34(10): 1325–1333. DOI: 10.1016/j.healun.2015.06.002.
  40. Hecker M, Hecker A, Kramm T, Askevold I, Kuhnert S, Reichert M, et al. Use of very old donors for lung transplantation: a dual-centre retrospective analysis. Eur J Cardio-Thorac Surg 2017;52(6):1049–1054. DOI: 10.1093/ejcts/ezx202.
  41. Sabashnikov A, Patil NP, Mohite PN, Sáez DG, Zych B, Popov AF, et al. Influence of donor smoking on midterm outcomes after lung transplantation. Ann Thorac Surg 2014;97(3):1015–1021. DOI: 10.1016/j.athoracsur.2013.11.020.
  42. Belousova N, Ma J, Wu J, deHaas E, Vasileva A, Huang QW, et al. Effects of donor smoking history on early post-transplant lung function measured by oscillometry. J Heart Lung Transplant 2020;39(4): S309–S310. DOI: 10.1016/j.healun.2021.01.1063.
  43. Somers J, Ruttens D, Verleden SE, Cox B, Stanzi A, Vandermeulen E, et al. A decade of extended-criteria lung donors in a single center: was it justified? Transplant Int 2015;28(2):170–179. DOI: 10.1111/tri.12470.
  44. Oto T, Griffiths A, Levvey B, Whitford H, Kotsimbos TC, Rabinov M, et al. Donor history of asthma is not a contraindication to lung transplantation: 12-year single-center experience. J Heart Lung Transplant 2004;23(3):309–316. DOI: 10.1016/S1053-2498(03)00192-X.
  45. Orens JB, Boehler A, De Perrot M, Estenne M, Glanville AR, Keshavjee S, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003;22(11):1183–1200. DOI: 10.1016/s1053-2498(03)00096-2.
  46. Srinivas TR, Shoskes DA, editors. Kidney and pancreas transplantation: a practical guide. Humana Press; 2011.
  47. Aref A, Zayan T, Pararajasingam R, Sharma A, Halawa A. Pancreatic transplantation: Brief review of the current evidence. World J Transplant 2019;9(4):81. DOI: 10.5500/wjt.v9.i4.81.
  48. Matsumoto CS, Subramanian S, Fishbein TM. Adult intestinal transplantation. Gastroenterol Clin North Am 2018;47(2):341. DOI: 10.1016/j.gtc.2018.01.011.
  49. Pironi L, Hébuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol 2006;101(7): 1633–1643. DOI: 10.1111/j.1572-0241.2006.00710.x.
  50. Roskott AM, Groen H, Rings EH, Haveman JW, Ploeg RJ, Serlie MJ, et al. Cost-effectiveness of intestinal transplantation for adult patients with intestinal failure: a simulation study. Am J Clin Nutr 2015;101(1): 79–86. DOI: 10.3945/ajcn.114.083303.
  51. Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol 2021;107(2):173. DOI: 10.1111/ejh.13665.
  52. Dotan A, Shoenfeld Y. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun 2021;121:102663. DOI: 10.1016/j.jaut.2021.102663.
  53. Chen PW, Tsai ZY, Chao TH, Li YH, Hou CJ, Liu PY. Addressing vaccine-induced immune thrombotic thrombocytopenia (VITT) following COVID-19 vaccination: a mini-review of practical strategies. Acta Cardiol Sin 2021;37(4):355. DOI: 10.6515/ACS.202107_37(4).20210628A.
  54. Greenhall GH, Ushiro-Lumb I, Pavord S, Currie I, Perera MT, Hartog H, et al. Organ transplantation from deceased donors with vaccine-induced thrombosis and thrombocytopenia. Am J Transplant 2021. DOI: 10.1111/ajt.16735.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.